PharMEDium Recalls Potassium Phosphate Injection Due to Sterility Concerns
PharMEDium Services is recalling specific lots of Potassium Phosphate in 5% Dextrose Injection because a media fill failure at the manufacturer raised concerns about sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or hospitalization if contaminated.
Plain-English summary
PharMEDium Services, LLC is recalling specific lots of Potassium PHOSphate in 5% Dextrose Injection, 15 mMol in 250 mL in 250 mL Intravia Bag Service. The recall is being conducted due to a lack of assurance of sterility resulting from a media fill failure at the manufacturer.
The affected product is identified by Lot 171420030D with a date of 8/21/2017. The distribution pattern is listed as nationwide. The product is prescription-only and is identified by NDC# 61553-300-11.
Healthcare providers and patients should stop using the affected product and contact PharMEDium Services, LLC at 800-523-7749 for further instructions or to arrange for a return or replacement.
The recalled product
- Product
- Potassium PHOSphate in 5% Dextrose Injection, 15 mMol in 250 mL in 250 mL Intravia Bag Service, Rx Only. PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5300 NDC# 61553-300-11
- Manufacturer
- PharMedium Services, Llc
- Category
- Drug — Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 171420030D
- 8/21/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by PharMedium Services, Llc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · PharMedium Services, Llc
See all →- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Infusions Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmedium Recalls Dexamethasone Sodium Phosphate Infusions Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- ModeratePharmedium Recalls Potassium Phosphate Bags With Incorrect Volume Labeling
FDA (Drugs) · 2017-06-21
- ModeratePharmedium Recalls Potassium Chloride Injection Bags Due to Labeling Error
FDA (Drugs) · 2016-06-15
- SeverePharmedium Recalls Potassium Chloride in 5% Dextrose Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SeverePharmedium Recalls Dexamethasone Sodium Phosphate Due to Sterility Assurance Issues
FDA (Drugs) · 2018-02-28
- HighIV Potassium Phosphate Solution Recalled Due to Sterility Concerns
FDA (Drugs) · 2023-05-31